WallStreetZenWallStreetZen

NASDAQ: ACTU
Actuate Therapeutics Inc Stock Ownership - Who owns Actuate Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Actuate Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel M. SchmittCEO;Pres;Dir2026-10-28140,844$0.36
$50.00kBuy
Daniel M. SchmittCEO;Pres;Dir2026-08-14120,521$1.01
$121.73kSell
Daniel M. SchmittPresident CEO and Director2026-02-13121,874$4.33
$527.71kSell
Todd S. ThomsonDirector2026-01-05280,000$5.80
$1.62MSell

1 of 1

ACTU insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACTU insiders and whales buy or sell their stock.

ACTU Shareholders

What type of owners hold Actuate Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bios Equity Cof LP42.46%10,196,456$3.42MInsider
Leslie W. Kreis42.46%10,196,456$3.42MInsider
Aaron Gl Fletcher42.46%10,196,456$3.42MInsider
Todd S. Thomson9.80%2,354,344$788.71kInsider
Daniel M. Schmitt7.10%1,704,040$570.85kInsider
Biosca0.04%10,050$3.37kInstitution
Bios Capital Management LP0.04%10,050$3.37kInstitution
Vossca0.01%1,725$577.88Institution
Voss Capital LP0.01%1,725$577.88Institution
Vangrd0.00%393$131.66Institution

1 of 3

ACTU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACTU0.04%99.96%Net SellingNet Buying
CURX0.01%99.99%
TPST0.00%100.00%Net Buying
ENSC0.00%20.27%Net BuyingNet Buying
TOVX0.00%0.54%
View Top Biotech Stocks

Actuate Therapeutics Stock Ownership FAQ

Who owns Actuate Therapeutics?

Actuate Therapeutics (NASDAQ: ACTU) is owned by 0.06% institutional shareholders, 144.28% Actuate Therapeutics insiders, and 0.00% retail investors. Bios Equity Cof LP is the largest individual Actuate Therapeutics shareholder, owning 10.20M shares representing 42.46% of the company. Bios Equity Cof LP's Actuate Therapeutics shares are currently valued at $3.42M.

If you're new to stock investing, here's how to buy Actuate Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.